Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease
Recruiting now · Not applicable
Conditions studied: Congenital Heart Disease in Children, Neurodevelopmental Disorders
In brief
Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease
Key facts
- Study ID
- NCT06431269
- Run by
- University Hospital, Montpellier
- People needed
- 270
- Starts
- 2024-05-31
- Expected to finish
- 2028-06-01
- Last updated by the study team
- 2025-09-25
Who can join
Age: 1 and older, up to 5. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Congenital heart disease with stable status defined by last operation >3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
- Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
- Patient aged 1 to 5 years.
- No previous medical diagnosis of NDD
- Parental or legal guardian's consent.
- Social security affiliation (for France only)
You may not qualify if…
- Patients with a genetic or poly-malformative syndrome with known neurological impairment.
- Neurodevelopmental disorder already known/treated
- Neurodevelopmental status evaluation within the last 6 months.
Where it is running
- University Hospitial of Montpellier — Montpellier, France (enrolling)
- Institut Marin Saint-Pierre — Palavas-les-Flots, France
- CHU Bordeaux Haut-Lévêque — Pessac, France
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.